Dr. Amanda Ching-Wun Cheung, MD

Dr. Cheung practices at Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare.

Dr. Cheung's NPI, 1548585193, was assigned on April 6, 2010. Dr. Cheung graduated from University of South Carolina School of Medicine in 2010. Dr. Cheung holds Illinois license 036131830.

Dr. Cheung's primary practice is Northwestern Memorial Hospital, at 251 E Huron St, Chicago, IL 60611 in Cook County. The practice phone is (312) 926-2000.

Dr. Cheung's primary practice is Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare. Dr. Cheung is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Cheung to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheung practices, 7 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Cheung's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dmand AI has Dr. Cheung's licenses on file in 2 states: Illinois and California.

CMS data shows 552 Medicare services from Dr. Cheung across 10 procedure codes in 2024, for 278 Medicare patients. Medicare paid $39,674 for them.

CMS counts 278 Medicare patients who saw Dr. Cheung in 2024. The largest group is 65 to 74, with 157 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheung's median patient age at 65, with 52% women.

In 2024, Dr. Cheung wrote 546 Medicare Part D claims for 100 patients. 84% of them were for generic drugs. CMS names the drug for 365 of them, across 11 drugs with 11 or more claims each, at $180,081 in total drug cost. In 2023, CMS named 458 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Cheung for performance year 2024, reported through an alternative payment model (APM). Dr. Cheung accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cheung as offering telehealth. CMS counts 25 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Cheung, more than 53% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Cheung, published from 2016 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Liver Transplantation, Biopsy and Critical Illness. Dr. Cheung has published most often in Clin Liver Dis. Dr. Cheung's most frequent co-authors are Paul Yien Kwo, MD, Mary E. Rinella, MD and Tami Jane Daugherty, MD.

CMS Open Payments shows 61 general payments to Dr. Cheung from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Novo Nordisk Inc paid the most, $52,373.

Dr. Cheung graduated from University of South Carolina School of Medicine in 2010.